Covered recipient · General Payments record
ROCHELLE RENEE REIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,884.71
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $379.04 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $90.37 | 5 |
| ABBVIE INC. | $79.30 | 4 |
| PFIZER INC. | $52.74 | 3 |
| Alkermes, Inc. | $42.86 | 2 |
| GlaxoSmithKline, LLC. | $39.31 | 2 |
| Axsome Therapeutics, Inc. | $32.54 | 1 |
| Acerta Pharma LLC | $22.56 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.36 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.10 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073345 | CMS |
| ABBVIE INC. | $25.77 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073347 | CMS |
| ABBVIE INC. | $20.74 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073349 | CMS |
| ABBVIE INC. | $14.69 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108073351 | CMS |
| Alkermes, Inc. | $22.57 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120579943 | CMS |
| Alkermes, Inc. | $20.29 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120579945 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104274831 | CMS |
| Axsome Therapeutics, Inc. | $32.54 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148404259 | CMS |
| GlaxoSmithKline, LLC. | $20.28 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116626330 | CMS |
| GlaxoSmithKline, LLC. | $19.03 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116607780 | CMS |
| Novo Nordisk Inc | $18.70 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100513137 | CMS |
| Novo Nordisk Inc | $13.83 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100528269 | CMS |
| Novo Nordisk Inc | $15.06 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100257052 | CMS |
| Novo Nordisk Inc | $19.20 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577408 | CMS |
| Novo Nordisk Inc | $23.58 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100506417 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.36 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119169986 | CMS |
| PFIZER INC. | $18.58 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131302915 | CMS |
| PFIZER INC. | $16.81 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132038364 | CMS |
| PFIZER INC. | $17.35 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131001369 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.